Chronic kidney disease (CKD), defined as dysfunction of the glomerular filtration apparatus,
is an independent risk factor for the development of coronary artery disease (CAD). Patients …

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality among
patients with end-stage renal disease (ESRD). Clustering of traditional atherosclerotic and …

Background The diagnostic and prognostic utility of risk factors proposed by the 2012
American Heart Association and American College of Cardiology Foundation (AHA/ACCF) …

BACKGROUND: Advanced chronic kidney disease is associated with high cardiovascular
risk, even after kidney transplant. Pretransplant cardiac testing may identify patients who …

Cardiac risk assessment before kidney transplantation has become widely accepted.
However, the optimal patient selection and screening tool for cardiac assessment remain …

Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …

Purpose Noninvasive stress testing is commonly performed as part of pre-renal
transplantation (RT) evaluation. We evaluated the prognostic value of myocardial perfusion …

Regadenoson is a selective A 2A adenosine receptor agonist that has been approved as a
vasodilator stress agent with single-photon emission-computed tomography (SPECT) …

Background Kidney transplantation provides substantial benefits in extending survival and
improving quality of life for patients with end-stage renal disease (ESRD). The incidence of …

Background Data on the prognostic value of regadenoson SPECT myocardial perfusion
imaging (MPI) is limited and based on small cohorts. Methods and Results We conducted a …